Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
17.60
-0.26 (-1.46%)
May 20, 2026, 11:44 AM CST

SHE:000623 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,1441,1631,1071,7201,4381,743
Short-Term Investments
----788704
Trading Asset Securities
1,7531,8001,5681,6581,6402,189
Cash & Short-Term Investments
2,8972,9632,6753,3783,8664,635
Cash Growth
9.31%10.76%-20.81%-12.62%-16.59%2.71%
Accounts Receivable
1,0071,0011,1571,4071,056964.31
Other Receivables
61.5525.2523.1829.9860.3168.53
Receivables
1,0691,0271,1811,4371,1161,033
Inventory
823.1802.1936.9872.35874.57591.88
Prepaid Expenses
-----0.16
Other Current Assets
68.8531.3840.4157.55124.6965.59
Total Current Assets
4,8584,8234,8335,7455,9826,326
Property, Plant & Equipment
2,3312,3562,5582,5342,3392,296
Long-Term Investments
27,30026,47324,64723,00321,89119,637
Other Intangible Assets
396.89404.52437.32435.35365.08359.61
Long-Term Deferred Tax Assets
279.73269.99326.23309.84303.12164.27
Long-Term Deferred Charges
39.7137.63111.57163.96212.25188.02
Other Long-Term Assets
60.5754.0488.3375.7789.8396.53
Total Assets
35,26634,41833,00232,26631,18229,067
Accounts Payable
332.92310.42425.71418.59450.97238.22
Accrued Expenses
93.9113.71106.87148.94183.15111.71
Short-Term Debt
905.62903.021,255678.31651.27355.52
Current Portion of Long-Term Debt
40.7624.07-2,315--
Current Portion of Leases
-9.2922.4817.8818.2325.41
Current Income Taxes Payable
25.043.595.928.2811.5219.31
Current Unearned Revenue
30.4431.6836.2526.2682.2518.36
Other Current Liabilities
614.28618.28611.75834.8817.97687.19
Total Current Liabilities
2,0432,0142,4644,4682,2151,456
Long-Term Debt
1,3001,299995.22-2,3032,211
Long-Term Leases
2.863.1816.5121.4917.5523.38
Long-Term Unearned Revenue
206.91212.98223.87247.38281.6313.86
Long-Term Deferred Tax Liabilities
0.851.3620.1730.0326.0624.21
Total Liabilities
3,5533,5313,7204,7674,8444,029
Common Stock
1,1961,1961,1961,1681,1631,163
Additional Paid-In Capital
4,8594,8984,8524,0353,9473,980
Retained Earnings
25,14124,27522,46621,87120,74119,243
Treasury Stock
-420.01-420.01-300-720.07-570.07-400.03
Comprehensive Income & Other
717.27717.38814.1856.99753.71873.11
Total Common Equity
31,49330,66729,02827,21226,03424,859
Minority Interest
219.42220.23254.65288.01303.54179.26
Shareholders' Equity
31,71330,88729,28227,50026,33825,039
Total Liabilities & Equity
35,26634,41833,00232,26631,18229,067
Total Debt
2,2492,2392,2893,0322,9902,616
Net Cash (Debt)
647.98724385.96346.02875.842,020
Net Cash Growth
137.88%87.58%11.54%-60.49%-56.63%-0.57%
Net Cash Per Share
0.550.620.330.270.671.60
Filing Date Shares Outstanding
1,1721,1721,1721,1231,1271,139
Total Common Shares Outstanding
1,1721,1721,1801,1231,1271,139
Working Capital
2,8152,8092,3691,2773,7674,870
Book Value Per Share
26.8626.1624.6124.2323.1021.83
Tangible Book Value
31,09630,26228,59026,77625,66924,500
Tangible Book Value Per Share
26.5225.8124.2423.8422.7821.51
Buildings
-2,2902,2872,2022,1382,039
Machinery
-1,5341,5121,4911,4131,321
Construction In Progress
-324.63424.87349.54177.36179.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.